Category: Health

Statewide initiative with the Ohio Association of Community Health Centers, CareSource, and Humana more than doubled Pregnancy Risk Assessment Form submission rates, accelerating identification of high-risk pregnancies and strengthening Medicaid continuity

BURLINGTON, Mass. — [April 30, 2026] — Azara Healthcare, the four-time Best in KLAS provider of population health and value-based care solutions for the safety net, together with the Ohio Association of Community Health Centers (OACHC), CareSource, and Humana, has received a 2026 KLAS Points of Light Award. The award recognizes the collaborators’ work to automate the creation and submission of Pregnancy Risk Assessment Forms (PRAFs) across Ohio, which more than doubled statewide submission rates and accelerated the identification of high-risk pregnancies covered by Medicaid. The collaboration is documented in case study titled “Improving Maternal Health in Ohio via Interoperability & Incentivized Care.”

Before the initiative, only about 30% of PRAFs were being submitted statewide, leaving many Medicaid-covered pregnancies unreported to the state and delaying the identification of high-risk mothers. Physicians were completing PRAFs on paper or in standalone web forms, manually locating and re-entering information already documented in the EHR, a process that routinely took 15 to 20 minutes per patient.

To solve the problem, OACHC convened community health centers, seven Managed Care Organizations including CareSource and Humana, the Ohio Department of Medicaid, the Ohio College of Medicine Government Resource Center, and Azara Healthcare. The MCOs jointly funded a single electronic PRAF (ePRAF) solution so provider partners would not bear implementation costs. Azara added a new module to the existing Ohio Data Integration Platform, powered by Azara. The additional tool automatically populates ePRAFs using data already documented in the EHR and securely transmits the information to ODM’s NurtureOhio portal.

“For safety-net providers caring for Ohio’s most vulnerable mothers, the barrier to better maternal outcomes has never been a lack of clinical insight—it’s been the administrative burden of getting that insight into the right hands in time to act on it,” said LuAnn Kimker, SVP of Clinical Innovation at Azara Healthcare. “By automating the PRAF workflow inside the tools providers already use every day, we’ve ensured that high-risk pregnancies are identified and coordinated earlier. This is what interoperability looks like when it’s built around the clinician and the patient, not around the form.”

The results have been significant. – 

The KLAS Points of Light Award recognizes successful collaborations between payers, providers, and healthcare technology companies that have led to measurable improvements in patient experience, cost, and efficiency.

Building on the initiative’s success, the collaborators plan to extend automation across the pregnancy continuum, including additional PRAF submissions triggered by changes in maternal risk, and the electronic capture of delivery and postpartum data. The ePRAF model is also positioned as a replicable blueprint for other states and for additional Medicaid and public health reporting use cases.

The full case study is available here.

Apr 29 (BNP): India is rapidly positioning itself as one of the world’s most accessible destinations for CAR-T cell therapy, driven by advances in biotechnology and more affordable treatment options, according to ImmunoACT.

The company highlighted that India’s growing capabilities in cell and gene therapy are helping make advanced cancer treatments more accessible to patients, both domestically and internationally. CAR-T therapy, which involves modifying a patient’s immune cells to target cancer, is considered a breakthrough in oncology but remains highly expensive in many parts of the world.

Industry experts note that India’s cost advantage, expanding clinical infrastructure, and skilled scientific talent pool are contributing to its emergence as a competitive global centre for advanced therapies. This is also supported by increasing investment in biotech research and stronger collaboration between academia and industry.

ImmunoACT said that India’s progress in this field reflects a broader shift toward innovation-led healthcare solutions that are both effective and affordable. The country is also focusing on scaling up production capabilities and improving regulatory pathways to support faster access to such therapies.

With growing global interest in cost-effective cancer treatment solutions, India is expected to play a more significant role in the future of cell and gene therapy worldwide.

The development marks a key milestone in the country’s journey toward becoming a global hub for advanced medical innovation and accessible healthcare technologies.

New Delhi, Apr 28 (BNP): Dr. Hemant Barua has been honoured with the prestigious Rastriya Ratan Samman in recognition of his contributions to research and practice in Vedic astrology.

The award ceremony was held on April 25 at Bharat Mandapam, New Delhi, where eminent personalities from various fields gathered to celebrate achievements across specialised domains.

The honour was presented by actress and Member of Parliament Kangana Ranaut at an event organised by VKonnet Star, which recognised individuals for excellence in knowledge-based and cultural fields.

Dr. Barua was acknowledged for his extensive work in modern Vedic astrology, including research efforts aimed at making traditional astrological knowledge more structured and relevant for contemporary audiences. Organisers highlighted his contribution in promoting wider understanding and engagement with the discipline.

The recognition reflects the continued prominence of traditional knowledge systems in India and their evolving role alongside modern academic and analytical frameworks.

New Delhi, Apr 24 (BNP): The government has taken steps to further strengthen the quality assurance framework for medicines sold through Jan Aushadhi Kendras across the country by signing new Memorandums of Understanding (MoUs) with key agencies involved in the scheme.

The initiative aims to ensure that medicines available under the affordable healthcare programme continue to meet strict safety and quality standards. The Pradhan Mantri Bhartiya Janaushadhi Pariyojana provides low-cost generic medicines through a wide network of retail outlets, helping reduce healthcare expenses for millions of citizens.

Officials said the latest MoUs will enhance monitoring systems, strengthen coordination between implementing bodies, and improve quality testing processes for medicines supplied to Jan Aushadhi stores. The focus is on making the supply chain more robust and transparent.

At present, medicines under the scheme are sourced only from certified manufacturers and undergo quality checks before being distributed. The new arrangements are expected to further tighten these procedures and ensure greater consistency in standards across all outlets.

The government has been expanding the Jan Aushadhi network in recent years to improve access to affordable healthcare, particularly in rural and underserved regions.

Officials added that strengthening quality assurance will help boost public confidence in generic medicines and support the broader goal of making essential drugs more accessible and affordable across the country.

HOUSTON (April 23, 2026) – Dr. Damian Young, investigator at Texas Children’s Duncan Neurological Research Institute (Duncan NRI) and director of the Center for Drug Discovery at Baylor College of Medicine, along with collaborators, has been awarded a $6.7 million grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to develop new approaches to rapidly identify potential treatments for Alzheimer’s disease and related dementias with the goal of accelerating the discovery of new therapies. 

While Alzheimer’s is often associated with aging, researchers at Texas Children’s are uniquely positioned to study it. By examining how the brain develops and functions early in life, scientists can better understand how those same systems break down over time—revealing new opportunities to prevent and treat neurodegenerative disease.

This five-year project brings together experts in chemistry, artificial intelligence and translational science to tackle one of the most complex challenges in Alzheimer’s research—quickly identifying therapies that are both safe and effective.

“This grant will enable the most expansive screening effort to date for compounds targeting Alzheimer’s disease,” Dr. Young said. “By integrating cutting-edge biological insights from Alzheimer’s disease research worldwide with a highly innovative chemistry and machine learning platform, we aim to unlock new opportunities for discovery. This work will represent the first critical step toward developing transformative therapies for Alzheimer’s disease and related dementias.”

Alzheimer’s disease and related dementias affect millions of people worldwide, yet developing new treatments remains a slow and complex process. One of the biggest challenges is identifying which molecules can successfully target the biological drivers of disease and reach the brain in a safe and effective way.

To address this, Dr. Young’s team will use DNA-encoded chemical libraries, a technology that allows researchers to screen hundreds of millions of potential drug compounds at once. Each compound carries a unique DNA “barcode,” enabling scientists to quickly identify which molecules interact with proteins linked to Alzheimer’s.

The team will then use artificial intelligence and machine learning to analyze the data and predict which compounds are most likely to succeed—significantly reducing the time from early discovery to viable drug candidates. Ultimately, this approach is designed to shorten the timeline for identifying new treatments—bringing potential therapies to patients faster and with greater precision.

The project will move through multiple phases, starting with large-scale screening and advancing to refining the most promising compounds to improve their strength, safety and ability to reach the brain. Researchers will also explore whether existing drugs can be repurposed, potentially accelerating the path to clinical testing.

A key component of the project is its open science approach. Data and compounds generated—including results from screening more than 900 million unique compounds—will be shared publicly, enabling researchers worldwide to build on the findings and advance new treatments. An internal advisory board of Texas Children’s and Baylor faculty consisting of Drs. Huda Zoghbi, Joshua Shulman, Hugo Bellen, and Juan Botas will provide critical expertise in prioritizing protein targets most strongly implicated in Alzheimer’s disease.

The work will be supported in part through collaboration with the Structural Genomics Consortium, which will provide critical protein targets needed for the research.

This research reflects Texas Children’s commitment to solving the unsolvable by advancing innovative, collaborative approaches to complex neurological diseases. Insights gained from pediatric research often inform adult treatments, and discoveries in adult disease can in turn accelerate breakthroughs in children’s health. By bridging these areas, researchers at the Duncan NRI are helping drive progress across the full spectrum of neurological disease, with the goal of improving outcomes for patients of all ages. For patients and families affected by Alzheimer’s and related dementias, this work represents a critical step toward earlier detection, more effective treatments and ultimately, prevention.

When Alin Sherin Abraham’s parents met eight-month-old Dhriya, the recipient of Alin’s liver, for the first time.

Thiruvananthapuram, Apr 23: In a tribute to the life-saving act of organ donation, KIMSHEALTH, organised a special gathering of organ donors and children who underwent liver transplant. The event also witnessed  a deeply emotional moment, as the family of the ten month old donor Alin Sherin Abraham, met Dhriya, the eight month old who received Alin’s liver, for the first time. More than 100 people participated in this special gathering. 

Dr. M I Sahadulla, Chairman and Managing Director of KIMSHEALTH, said that organ is the noblest message of love and sacrifice. He emphasized that it not only conveys a powerful message to society, but also plays a vital role in raising awareness about this crucial cause. Dr.Sahadulla, also lauded the tireless efforts of government systems, doctors in the liver transplant department, and other staff members.

Dr.Nobel Gracious, Executive Director, K-SOTTO said that the cooperation of organ donors’ families in Kerala, government systems including the police, public, media and above all, the untiring efforts of the doctors and the medical team performing the transplants is a great model to follow. Being an organ donor is a generous and worthwhile decision that can be a lifesaver, he added.

Dr. P K Jabbar, Principal, Government Medical College Thiruvananthapuram; Dr. Ragi Krishnan, South Zone Nodal Officer K-SOTTO; Dr. Basil, Joint Director, K-SOTTO; Dr. Praveen Muralidharan, Director, Multi Organ Transplant, KIMSHEALTH; Liver Transplant surgeons Dr. Shiraz Ahmad Rather, Dr. Shabeerali T U, and Pediatric Hepatologist Dr. Anu K Vasu where also part of the program.

KIMSHEALTH performed its first liver transplant on July 23, 2013. Since then, nearly 250 liver transplant surgeries have been successfully completed. The hospital has also achieved several significant milestones, including Kerala’s first combined liver and kidney transplant, the state’s first split liver transplant, the successful liver transplant on a lowest weighing baby.

Apr 22 (BNP): The Indian life insurance sector has recorded a landmark achievement by collecting approximately ₹4 trillion in new business premiums in FY26, marking the highest-ever annual figure for the industry.

This milestone reflects strong consumer demand for life insurance products, increased financial awareness, and wider adoption across diverse market segments. Growth has been supported by digital transformation, improved accessibility, and expansion into emerging regions.

The industry’s performance highlights a growing focus on financial protection and long-term savings among Indian households. Insurers have also benefited from enhanced distribution capabilities and evolving product offerings tailored to customer needs.

The achievement underscores the sector’s steady expansion and its critical role in strengthening India’s financial security ecosystem.

Jaipur, Apr 20 (BNP): A recent clinical assessment conducted at a leading government hospital in Rajasthan has brought renewed attention to the growing impact of prolonged screen exposure on children’s physical, cognitive, and emotional well-being. The findings indicate a clear association between higher daily screen use and disturbances in attention, sleep patterns, and behavioural balance among school-going children.

 The study evaluated 150 children in the age group of 10 to 16 years using behavioural observations, structured interactions, and parental feedback. It reflects an emerging lifestyle trend where digital devices are increasingly central to both learning and leisure, often without structured limits.

According to the study

According to the study, nearly 72% of children reported spending between three and six hours daily on mobile phones. Researchers observed that this level of screen engagement is frequently accompanied by reduced concentration, irregular sleep cycles, and diminished participation in offline activities.

Children with higher screen exposure were more likely to show difficulty in sustaining attention during academic tasks, increased irritability, and a tendency to withdraw from face-to-face social interaction. A preference for digital engagement over physical or outdoor activities was also commonly noted.

Cognitive and behavioural impact

The findings suggest that prolonged and unregulated screen use may overstimulate developing cognitive systems, affecting a child’s ability to focus for extended periods. Exposure to fast-paced and constantly changing digital content can gradually reduce patience levels and weaken attention control, particularly in academic environments.

Behavioural observations also indicated subtle emotional changes, including increased reliance on digital devices for comfort and reduced engagement with family members and peers. Over time, this pattern may influence social development and emotional responsiveness.

Sleep disruption emerging as a key concern

One of the most consistent observations in the study relates to sleep disturbance. Excessive screen use, especially during evening hours, was linked to delayed sleep onset and reduced overall sleep quality. This disruption in sleep patterns can have wider implications on memory consolidation, mood stability, and daytime alertness.

A shifting childhood environment

The study highlights a broader transformation in childhood experiences, where digital interaction is replacing traditional forms of play and communication. While technology continues to offer educational benefits, the findings underline the need to understand its behavioural and developmental impact when used without boundaries.

The importance of balanced digital habits

Experts associated with the assessment emphasise that complete avoidance of digital devices is neither practical nor necessary. Instead, the focus should be on structured and age-appropriate screen-time management.

Recommended measures include limiting recreational screen use, encouraging outdoor physical activity, promoting family interaction, and maintaining device-free time before sleep. These steps are seen as essential in restoring balance between digital engagement and real-world experiences.

A growing developmental concern

The findings point toward an emerging public health and developmental concern, as screen dependency becomes increasingly common among children. While digital tools remain integral to modern life, the study underscores the importance of moderation to ensure healthy cognitive growth, emotional stability, and social development.

In an increasingly digital world, the challenge lies not in removing screens from childhood—but in ensuring they do not define it.